Myotonic dystrophy kinase‐related CDC42‐binding kinase α, a new transferrin receptor type 2‐binding partner, is a regulator of erythropoiesis

Efficient erythropoiesis relies on the expression of the transferrin receptor type 2 (TFR2). In erythroid precursors, TFR2 facilitates the export of the erythropoietin receptor (EPOR) to cell surface, which ensures the survival and proliferation of erythroblasts. Although TFR2 has a crucial role in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of hematology 2021-04, Vol.96 (4), p.480-492
Hauptverfasser: Richard, Cyrielle, Viret, Sophie, Cantero Aguilar, Lilia, Lefevre, Carine, Leduc, Marjorie, Faouzi, El Hassan, Azar, Nabih, Lavazec, Catherine, Mayeux, Patrick, Verdier, Frédérique
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 492
container_issue 4
container_start_page 480
container_title American journal of hematology
container_volume 96
creator Richard, Cyrielle
Viret, Sophie
Cantero Aguilar, Lilia
Lefevre, Carine
Leduc, Marjorie
Faouzi, El Hassan
Azar, Nabih
Lavazec, Catherine
Mayeux, Patrick
Verdier, Frédérique
description Efficient erythropoiesis relies on the expression of the transferrin receptor type 2 (TFR2). In erythroid precursors, TFR2 facilitates the export of the erythropoietin receptor (EPOR) to cell surface, which ensures the survival and proliferation of erythroblasts. Although TFR2 has a crucial role in erythropoiesis regulation, its mechanism of action remains to be clarified. To understand its role better, we aimed at identifying its protein partners by mass‐spectrometry after immunoprecipitation in erythroid cells. Here we report the kinase MRCKα (myotonic dystrophy kinase‐related CDC42‐binding kinase α) as a new partner of both TFR2 and EPOR in erythroblasts. We show that MRCKα is co‐expressed with TFR2, and TFR1 during terminal differentiation and regulates the internalization of the two types of transferrin receptors. The knockdown of MRCKα by shRNA in human primary erythroblasts leads to a decreased cell surface expression of both TFR1 and TFR2, an increased cell‐surface expression of EPOR, and a delayed differentiation. Additionally, knockout of Mrckα in the murine MEDEP cells also leads to a striking delay in erythropoiesis, showcasing the importance of this kinase in both species. Our data highlight the importance of MRCKα in the regulation of erythropoiesis.
doi_str_mv 10.1002/ajh.26104
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03400346v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2480311777</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4224-21b7a3f282c26b561028ada0fb12085c6534acaf9fb10856ae2228479bf7206f3</originalsourceid><addsrcrecordid>eNp1kc9u1DAQxi1ERZfCgRdAlriA1G1tx7GT42r5s6BFXOBsOcm46yVrB9uhyo1H4MCL9EX6EDwJbncpCImDZc_oN9-M50PoCSVnlBB2rrebMyYo4ffQjJJazCtRsvtoRgpB85vUx-hhjFtCKOUVeYCOi4JLwQs5Qz_eTz55Z1vcTTEFP2wm_Nk6HeHnt-8Bep2gw8uXS85y3FjXWXdxAPD11SnW2MElTkG7aCAE63CAFobkA07TAPjvskGH5CCcYhtzXYCLMctn0BsMYUqb3N1biDY-QkdG9xEeH-4T9On1q4_L1Xz94c3b5WI9bzljfM5oI3VhWMVaJpoyL4BVutPENJSRqmxFWXDdalPnRI6FBsZYxWXdGMmIMMUJerHX3eheDcHudJiU11atFmt1kyMFJ_mIrzSzz_fsEPyXEWJSOxtb6HvtwI9RsbzZglIpZUaf_YNu_Rhc_oliJckucFHLP83b4GMMYO4moETd2KqyrerW1sw-PSiOzQ66O_K3jxk43wOXtofp_0pq8W61l_wF4hivDw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2500014697</pqid></control><display><type>article</type><title>Myotonic dystrophy kinase‐related CDC42‐binding kinase α, a new transferrin receptor type 2‐binding partner, is a regulator of erythropoiesis</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><creator>Richard, Cyrielle ; Viret, Sophie ; Cantero Aguilar, Lilia ; Lefevre, Carine ; Leduc, Marjorie ; Faouzi, El Hassan ; Azar, Nabih ; Lavazec, Catherine ; Mayeux, Patrick ; Verdier, Frédérique</creator><creatorcontrib>Richard, Cyrielle ; Viret, Sophie ; Cantero Aguilar, Lilia ; Lefevre, Carine ; Leduc, Marjorie ; Faouzi, El Hassan ; Azar, Nabih ; Lavazec, Catherine ; Mayeux, Patrick ; Verdier, Frédérique</creatorcontrib><description>Efficient erythropoiesis relies on the expression of the transferrin receptor type 2 (TFR2). In erythroid precursors, TFR2 facilitates the export of the erythropoietin receptor (EPOR) to cell surface, which ensures the survival and proliferation of erythroblasts. Although TFR2 has a crucial role in erythropoiesis regulation, its mechanism of action remains to be clarified. To understand its role better, we aimed at identifying its protein partners by mass‐spectrometry after immunoprecipitation in erythroid cells. Here we report the kinase MRCKα (myotonic dystrophy kinase‐related CDC42‐binding kinase α) as a new partner of both TFR2 and EPOR in erythroblasts. We show that MRCKα is co‐expressed with TFR2, and TFR1 during terminal differentiation and regulates the internalization of the two types of transferrin receptors. The knockdown of MRCKα by shRNA in human primary erythroblasts leads to a decreased cell surface expression of both TFR1 and TFR2, an increased cell‐surface expression of EPOR, and a delayed differentiation. Additionally, knockout of Mrckα in the murine MEDEP cells also leads to a striking delay in erythropoiesis, showcasing the importance of this kinase in both species. Our data highlight the importance of MRCKα in the regulation of erythropoiesis.</description><identifier>ISSN: 0361-8609</identifier><identifier>EISSN: 1096-8652</identifier><identifier>DOI: 10.1002/ajh.26104</identifier><identifier>PMID: 33476437</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Animals ; cdc42 GTP-Binding Protein - metabolism ; Cdc42 protein ; Cell surface ; Cells, Cultured ; CRISPR-Cas Systems ; Endocytosis ; Erythroblasts ; Erythroblasts - cytology ; Erythroblasts - metabolism ; Erythroid cells ; Erythropoiesis ; Erythropoiesis - physiology ; Erythropoietin ; Gene Knockout Techniques ; Hematology ; Human health and pathology ; Humans ; Immunoprecipitation ; Internalization ; Iron - metabolism ; Life Sciences ; Mice ; Myotonic dystrophy ; Myotonin-Protein Kinase - isolation &amp; purification ; Myotonin-Protein Kinase - physiology ; Receptors, Erythropoietin - metabolism ; Receptors, Transferrin - metabolism ; RNA Interference ; RNA, Small Interfering - genetics ; RNA, Small Interfering - pharmacology ; Transferrin receptors ; Transferrins</subject><ispartof>American journal of hematology, 2021-04, Vol.96 (4), p.480-492</ispartof><rights>2021 Wiley Periodicals LLC.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4224-21b7a3f282c26b561028ada0fb12085c6534acaf9fb10856ae2228479bf7206f3</citedby><cites>FETCH-LOGICAL-c4224-21b7a3f282c26b561028ada0fb12085c6534acaf9fb10856ae2228479bf7206f3</cites><orcidid>0000-0001-7267-0298 ; 0000-0003-1533-7282 ; 0000-0002-4049-3976</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajh.26104$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajh.26104$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33476437$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03400346$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Richard, Cyrielle</creatorcontrib><creatorcontrib>Viret, Sophie</creatorcontrib><creatorcontrib>Cantero Aguilar, Lilia</creatorcontrib><creatorcontrib>Lefevre, Carine</creatorcontrib><creatorcontrib>Leduc, Marjorie</creatorcontrib><creatorcontrib>Faouzi, El Hassan</creatorcontrib><creatorcontrib>Azar, Nabih</creatorcontrib><creatorcontrib>Lavazec, Catherine</creatorcontrib><creatorcontrib>Mayeux, Patrick</creatorcontrib><creatorcontrib>Verdier, Frédérique</creatorcontrib><title>Myotonic dystrophy kinase‐related CDC42‐binding kinase α, a new transferrin receptor type 2‐binding partner, is a regulator of erythropoiesis</title><title>American journal of hematology</title><addtitle>Am J Hematol</addtitle><description>Efficient erythropoiesis relies on the expression of the transferrin receptor type 2 (TFR2). In erythroid precursors, TFR2 facilitates the export of the erythropoietin receptor (EPOR) to cell surface, which ensures the survival and proliferation of erythroblasts. Although TFR2 has a crucial role in erythropoiesis regulation, its mechanism of action remains to be clarified. To understand its role better, we aimed at identifying its protein partners by mass‐spectrometry after immunoprecipitation in erythroid cells. Here we report the kinase MRCKα (myotonic dystrophy kinase‐related CDC42‐binding kinase α) as a new partner of both TFR2 and EPOR in erythroblasts. We show that MRCKα is co‐expressed with TFR2, and TFR1 during terminal differentiation and regulates the internalization of the two types of transferrin receptors. The knockdown of MRCKα by shRNA in human primary erythroblasts leads to a decreased cell surface expression of both TFR1 and TFR2, an increased cell‐surface expression of EPOR, and a delayed differentiation. Additionally, knockout of Mrckα in the murine MEDEP cells also leads to a striking delay in erythropoiesis, showcasing the importance of this kinase in both species. Our data highlight the importance of MRCKα in the regulation of erythropoiesis.</description><subject>Animals</subject><subject>cdc42 GTP-Binding Protein - metabolism</subject><subject>Cdc42 protein</subject><subject>Cell surface</subject><subject>Cells, Cultured</subject><subject>CRISPR-Cas Systems</subject><subject>Endocytosis</subject><subject>Erythroblasts</subject><subject>Erythroblasts - cytology</subject><subject>Erythroblasts - metabolism</subject><subject>Erythroid cells</subject><subject>Erythropoiesis</subject><subject>Erythropoiesis - physiology</subject><subject>Erythropoietin</subject><subject>Gene Knockout Techniques</subject><subject>Hematology</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Immunoprecipitation</subject><subject>Internalization</subject><subject>Iron - metabolism</subject><subject>Life Sciences</subject><subject>Mice</subject><subject>Myotonic dystrophy</subject><subject>Myotonin-Protein Kinase - isolation &amp; purification</subject><subject>Myotonin-Protein Kinase - physiology</subject><subject>Receptors, Erythropoietin - metabolism</subject><subject>Receptors, Transferrin - metabolism</subject><subject>RNA Interference</subject><subject>RNA, Small Interfering - genetics</subject><subject>RNA, Small Interfering - pharmacology</subject><subject>Transferrin receptors</subject><subject>Transferrins</subject><issn>0361-8609</issn><issn>1096-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc9u1DAQxi1ERZfCgRdAlriA1G1tx7GT42r5s6BFXOBsOcm46yVrB9uhyo1H4MCL9EX6EDwJbncpCImDZc_oN9-M50PoCSVnlBB2rrebMyYo4ffQjJJazCtRsvtoRgpB85vUx-hhjFtCKOUVeYCOi4JLwQs5Qz_eTz55Z1vcTTEFP2wm_Nk6HeHnt-8Bep2gw8uXS85y3FjXWXdxAPD11SnW2MElTkG7aCAE63CAFobkA07TAPjvskGH5CCcYhtzXYCLMctn0BsMYUqb3N1biDY-QkdG9xEeH-4T9On1q4_L1Xz94c3b5WI9bzljfM5oI3VhWMVaJpoyL4BVutPENJSRqmxFWXDdalPnRI6FBsZYxWXdGMmIMMUJerHX3eheDcHudJiU11atFmt1kyMFJ_mIrzSzz_fsEPyXEWJSOxtb6HvtwI9RsbzZglIpZUaf_YNu_Rhc_oliJckucFHLP83b4GMMYO4moETd2KqyrerW1sw-PSiOzQ66O_K3jxk43wOXtofp_0pq8W61l_wF4hivDw</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Richard, Cyrielle</creator><creator>Viret, Sophie</creator><creator>Cantero Aguilar, Lilia</creator><creator>Lefevre, Carine</creator><creator>Leduc, Marjorie</creator><creator>Faouzi, El Hassan</creator><creator>Azar, Nabih</creator><creator>Lavazec, Catherine</creator><creator>Mayeux, Patrick</creator><creator>Verdier, Frédérique</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><general>Wiley</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-7267-0298</orcidid><orcidid>https://orcid.org/0000-0003-1533-7282</orcidid><orcidid>https://orcid.org/0000-0002-4049-3976</orcidid></search><sort><creationdate>20210401</creationdate><title>Myotonic dystrophy kinase‐related CDC42‐binding kinase α, a new transferrin receptor type 2‐binding partner, is a regulator of erythropoiesis</title><author>Richard, Cyrielle ; Viret, Sophie ; Cantero Aguilar, Lilia ; Lefevre, Carine ; Leduc, Marjorie ; Faouzi, El Hassan ; Azar, Nabih ; Lavazec, Catherine ; Mayeux, Patrick ; Verdier, Frédérique</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4224-21b7a3f282c26b561028ada0fb12085c6534acaf9fb10856ae2228479bf7206f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>cdc42 GTP-Binding Protein - metabolism</topic><topic>Cdc42 protein</topic><topic>Cell surface</topic><topic>Cells, Cultured</topic><topic>CRISPR-Cas Systems</topic><topic>Endocytosis</topic><topic>Erythroblasts</topic><topic>Erythroblasts - cytology</topic><topic>Erythroblasts - metabolism</topic><topic>Erythroid cells</topic><topic>Erythropoiesis</topic><topic>Erythropoiesis - physiology</topic><topic>Erythropoietin</topic><topic>Gene Knockout Techniques</topic><topic>Hematology</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Immunoprecipitation</topic><topic>Internalization</topic><topic>Iron - metabolism</topic><topic>Life Sciences</topic><topic>Mice</topic><topic>Myotonic dystrophy</topic><topic>Myotonin-Protein Kinase - isolation &amp; purification</topic><topic>Myotonin-Protein Kinase - physiology</topic><topic>Receptors, Erythropoietin - metabolism</topic><topic>Receptors, Transferrin - metabolism</topic><topic>RNA Interference</topic><topic>RNA, Small Interfering - genetics</topic><topic>RNA, Small Interfering - pharmacology</topic><topic>Transferrin receptors</topic><topic>Transferrins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Richard, Cyrielle</creatorcontrib><creatorcontrib>Viret, Sophie</creatorcontrib><creatorcontrib>Cantero Aguilar, Lilia</creatorcontrib><creatorcontrib>Lefevre, Carine</creatorcontrib><creatorcontrib>Leduc, Marjorie</creatorcontrib><creatorcontrib>Faouzi, El Hassan</creatorcontrib><creatorcontrib>Azar, Nabih</creatorcontrib><creatorcontrib>Lavazec, Catherine</creatorcontrib><creatorcontrib>Mayeux, Patrick</creatorcontrib><creatorcontrib>Verdier, Frédérique</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>American journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Richard, Cyrielle</au><au>Viret, Sophie</au><au>Cantero Aguilar, Lilia</au><au>Lefevre, Carine</au><au>Leduc, Marjorie</au><au>Faouzi, El Hassan</au><au>Azar, Nabih</au><au>Lavazec, Catherine</au><au>Mayeux, Patrick</au><au>Verdier, Frédérique</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Myotonic dystrophy kinase‐related CDC42‐binding kinase α, a new transferrin receptor type 2‐binding partner, is a regulator of erythropoiesis</atitle><jtitle>American journal of hematology</jtitle><addtitle>Am J Hematol</addtitle><date>2021-04-01</date><risdate>2021</risdate><volume>96</volume><issue>4</issue><spage>480</spage><epage>492</epage><pages>480-492</pages><issn>0361-8609</issn><eissn>1096-8652</eissn><abstract>Efficient erythropoiesis relies on the expression of the transferrin receptor type 2 (TFR2). In erythroid precursors, TFR2 facilitates the export of the erythropoietin receptor (EPOR) to cell surface, which ensures the survival and proliferation of erythroblasts. Although TFR2 has a crucial role in erythropoiesis regulation, its mechanism of action remains to be clarified. To understand its role better, we aimed at identifying its protein partners by mass‐spectrometry after immunoprecipitation in erythroid cells. Here we report the kinase MRCKα (myotonic dystrophy kinase‐related CDC42‐binding kinase α) as a new partner of both TFR2 and EPOR in erythroblasts. We show that MRCKα is co‐expressed with TFR2, and TFR1 during terminal differentiation and regulates the internalization of the two types of transferrin receptors. The knockdown of MRCKα by shRNA in human primary erythroblasts leads to a decreased cell surface expression of both TFR1 and TFR2, an increased cell‐surface expression of EPOR, and a delayed differentiation. Additionally, knockout of Mrckα in the murine MEDEP cells also leads to a striking delay in erythropoiesis, showcasing the importance of this kinase in both species. Our data highlight the importance of MRCKα in the regulation of erythropoiesis.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>33476437</pmid><doi>10.1002/ajh.26104</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0001-7267-0298</orcidid><orcidid>https://orcid.org/0000-0003-1533-7282</orcidid><orcidid>https://orcid.org/0000-0002-4049-3976</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0361-8609
ispartof American journal of hematology, 2021-04, Vol.96 (4), p.480-492
issn 0361-8609
1096-8652
language eng
recordid cdi_hal_primary_oai_HAL_hal_03400346v1
source MEDLINE; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection)
subjects Animals
cdc42 GTP-Binding Protein - metabolism
Cdc42 protein
Cell surface
Cells, Cultured
CRISPR-Cas Systems
Endocytosis
Erythroblasts
Erythroblasts - cytology
Erythroblasts - metabolism
Erythroid cells
Erythropoiesis
Erythropoiesis - physiology
Erythropoietin
Gene Knockout Techniques
Hematology
Human health and pathology
Humans
Immunoprecipitation
Internalization
Iron - metabolism
Life Sciences
Mice
Myotonic dystrophy
Myotonin-Protein Kinase - isolation & purification
Myotonin-Protein Kinase - physiology
Receptors, Erythropoietin - metabolism
Receptors, Transferrin - metabolism
RNA Interference
RNA, Small Interfering - genetics
RNA, Small Interfering - pharmacology
Transferrin receptors
Transferrins
title Myotonic dystrophy kinase‐related CDC42‐binding kinase α, a new transferrin receptor type 2‐binding partner, is a regulator of erythropoiesis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T16%3A19%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Myotonic%20dystrophy%20kinase%E2%80%90related%20CDC42%E2%80%90binding%20kinase%20%CE%B1,%20a%20new%20transferrin%20receptor%20type%202%E2%80%90binding%20partner,%20is%20a%20regulator%20of%20erythropoiesis&rft.jtitle=American%20journal%20of%20hematology&rft.au=Richard,%20Cyrielle&rft.date=2021-04-01&rft.volume=96&rft.issue=4&rft.spage=480&rft.epage=492&rft.pages=480-492&rft.issn=0361-8609&rft.eissn=1096-8652&rft_id=info:doi/10.1002/ajh.26104&rft_dat=%3Cproquest_hal_p%3E2480311777%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2500014697&rft_id=info:pmid/33476437&rfr_iscdi=true